Double-blind study of the analgesic activity of fosfosal in patients with musculoskeletal and articular pain: comparison with lysine acetylsalicylate and placebo.
D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001847:Bone Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008239:Lysine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy*; D010755:Organophosphates / Q000009:adverse effects / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D010919:Placebos; D012459:Salicylates / Q000009:adverse effects / Q000627:therapeutic use*; D013270:Stomach / Q000187:drug effects
D000700:Analgesics; D010755:Organophosphates; D009943:Organophosphorus Compounds; D010919:Placebos; D012459:Salicylates; C000380:fosfosal; D008239:Lysine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate